It is currently unclear whether increased RCVRN expression in high‐risk AMD‐RPE is related to cell fate changes or to an impaired wound healing response and epithelial to mesenchymal transition which has already been reported in AMD‐RPE 44. The gene discussed is RCVRN; the disease is age-related macular degeneration.